Canada establishes rare disease Advisory Group

The Government of Canada has announced the establishment of an Implementation Advisory Group (IAG) for drugs for rare diseases.

The creation of the National Strategy for Drugs for Rare Diseases will aim to improve consistent access and affordability of effective drugs for rare diseases.

Over the next three years, the IAG will provide a forum for patients and stakeholders to exchange information, provide patient-centered advice and exchange, and establish best practices for the implementation of the National Strategy.

(orphanews International 2023.11.20)